{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-22-000023","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2022-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.743616+00:00","generated_at":"2026-06-25T03:26:12.287196+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Charles River lowers Q2 2022 revenue and EPS outlook, cites FX and CDMO headwinds","bullets":["Q2 reported revenue growth guidance cut from low-double-digit to high-single-digit YoY; non-GAAP EPS growth cut from mid- to high-single-digit to low- to mid-single-digit.","Guidance reduction driven by unfavorable FX impact and manufacturing (CDMO) revenue growth below Q1 2022 level.","DSA and RMS organic growth rates expected to accelerate from Q1; DSA trends remain in line with full-year expectations.","Full-year 2022 organic revenue growth and non-GAAP EPS guidance maintained within prior ranges provided in May."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-22-000023","json":"https://secwatch.observer/filing/0001100682-22-000023.json","markdown":"https://secwatch.observer/filing/0001100682-22-000023.md","text":"https://secwatch.observer/filing/0001100682-22-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/0001100682-22-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/crl-20220608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:26:12.287196+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}